"Over 200 patients now pre-screened, with rate of patient dosing expected to increase due to significant early engagement and ongoing support from Emerald Clinics."
Sounds like the dates provided in the trial registry ANZCTR would be worst case scenario and the language in this announcement means we will be ahead of schedule.
- Forums
- ASX - By Stock
- EMD
- Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial, page-5
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.29M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.2¢ | $8.187K | 248.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 202839 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 202839 | 0.032 |
5 | 219518 | 0.031 |
9 | 972385 | 0.030 |
4 | 110414 | 0.029 |
2 | 23000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 15000 | 1 |
0.041 | 32255 | 1 |
0.042 | 64500 | 1 |
0.043 | 12000 | 1 |
0.044 | 20000 | 1 |
Last trade - 13.34pm 14/11/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |